Valeant posts 4th-qtr loss, revenues downturn
OTTAWA: Canada’s Valeant Pharmaceuticals International (TSX: VRX) has released fourth-quarter and full-year 2016 results, showing that revenue fell 12.9% to ...
Tag: revenues downturn
Popular Stories
-
FBR, Pakistan Customs express concerns over recent transfers & postings
-
Lahore Appraisement foils bid to smuggle goods, items worth Rs1.36b
-
MTBA seeks action for early disposal of pending cases in ATIR
-
PM Shehbaz directs FBR to defer implementation of SRO 350
-
FBR introduces SMS service 9966 to facilitate taxpayers